Understanding the role of CDKs in cell cycle regulation has significant therapeutic implications. CDK inhibitors are being developed and tested for their efficacy in treating various cancers. By targeting specific CDKs, these inhibitors can potentially halt the proliferation of cancer cells, offering a targeted approach to cancer therapy. Ongoing research aims to identify novel CDK inhibitors and understand their mechanisms of action to improve their clinical efficacy.
